← Leaderboards
Mirianas Chachisvilis
La Jolla Bioengineering Institute
$9,759,996
Attributed
$9,908,205
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,908,205 · 6
By mechanism
R44$6,874,193 · 2
R01$2,735,409 · 1
R43$296,418 · 1
P41$2,185 · 2
Top collaborators
- Gerdenis Kodis1 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseHemodynamicsBlood VesselsBaseCoupledAffectPressureLeadMolecularPhysiologyDesignProgramsConformational ConversionMembrane ProteinsLipidsCostLipid BilayersMembraneGtp-Binding ProteinsLateralEndothelial CellsCell MembraneG-Protein-Coupled ReceptorsDiffusion
Grant awards (20)
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$742,845
R44 · FY2024 · CA · contact PI
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$757,314
R44 · FY2023 · CA · contact PI
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$1,499,425
R44 · FY2022 · CA · contact PI
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$833,460
R44 · FY2021 · CA · contact PI
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$1,164,975
R44 · FY2020 · CA · contact PI
Hemodynamic Noninvasive Skin Cancer Diagnostics$2,000
R44 · FY2018 · CA · contact PI
Hemodynamic Noninvasive Skin Cancer Diagnostics$896,930
R44 · FY2017 · CA · contact PI
Hemodynamic Noninvasive Skin Cancer Diagnostics$521,409
R44 · FY2016 · CA · contact PI
Hemodynamic Noninvasive Skin Cancer Diagnostics$455,835
R44 · FY2016 · CA · contact PI
Chiral separation and analysis by molecular propeller effect$296,418
R43 · FY2016 · GM
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$104,664
R01 · FY2012 · HL · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$530,046
R01 · FY2011 · HL · contact PI
MECHANOSENSITIVITY OF CELL MEMBRANES: ROLE OF LIPID-PROTEIN INTERACTIONS$1,094
P41 · FY2011 · RR · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$426,150
R01 · FY2010 · HL · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$61,385
R01 · FY2010 · HL · contact PI
MECHANOSENSITIVITY OF CELL MEMBRANES: ROLE OF LIPID-PROTEIN INTERACTIONS$1,091
P41 · FY2010 · RR · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$426,150
R01 · FY2009 · HL · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$382,064
R01 · FY2009 · HL · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$426,150
R01 · FY2008 · HL · contact PI
Mechanosensitivity of Cell Membranes: Role of Lipid-Protein Interactions$378,800
R01 · FY2007 · HL · contact PI